S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
NASDAQ:NAUT

Nautilus Biotechnology News Headlines

$4.43
-0.06 (-1.34%)
(As of 01/14/2022 12:00 AM ET)
Add
Compare
Today's Range
$4.21
$4.56
50-Day Range
$4.43
$6.04
52-Week Range
$4.21
$25.89
Volume
423,458 shs
Average Volume
441,387 shs
Market Capitalization
$550.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Get Nautilus Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAUT and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Nautilus Biotechnology Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NAUT
News Sentiment

-0.16

0.31

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NAUT Articles
This Week

3

1

NAUT Articles
Average Week



Nautilus Biotechnology (NASDAQ:NAUT) News Headlines Today

SourceHeadline
MarketBeat logo Analysts Anticipate Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Will Post Earnings of -$0.15 Per Share
americanbankingnews.com - January 16 at 12:14 AM
nasdaq.com logoNautilus Biotechnology Inc Shares Approach 52-Week Low - Market Mover
nasdaq.com - January 14 at 11:21 PM
MarketBeat logoNautilus Biotechnology (NASDAQ:NAUT) Reaches New 1-Year Low at $4.35
americanbankingnews.com - January 14 at 3:00 PM
MarketBeat logoNautilus Biotechnology (NASDAQ:NAUT) and 10x Genomics (NASDAQ:TXG) Critical Review
americanbankingnews.com - January 7 at 4:14 PM
MarketBeat logoNautilus Biotechnology (NASDAQ:NAUT) Shares Gap Down to $5.77
americanbankingnews.com - December 28 at 11:22 AM
MarketBeat logo Brokerages Expect Nautilus Biotechnology, Inc. (NASDAQ:NAUT) to Post -$0.14 Earnings Per Share
americanbankingnews.com - December 26 at 6:10 PM
MarketBeat logoContrasting Waters (NYSE:WAT) and Nautilus Biotechnology (NASDAQ:NAUT)
americanbankingnews.com - December 24 at 5:08 PM
MarketBeat logoComparing Nautilus Biotechnology (NASDAQ:NAUT) and Bio-Rad Laboratories (NYSE:BIO)
americanbankingnews.com - December 23 at 3:14 PM
MarketBeat logoNautilus Biotechnology (NASDAQ:NAUT) Shares Gap Up to $5.27
americanbankingnews.com - December 22 at 10:40 AM
nasdaq.com logoTrade Alert: The Co-Founder Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT), Sujal Patel, Has Just Spent US$1.2m Buying 1.5% More Shares
nasdaq.com - December 5 at 10:22 PM
finance.yahoo.com logoNautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome
finance.yahoo.com - November 2 at 9:58 AM
finance.yahoo.com logoNautilus Biotechnology Inc (NAUT): Hedge Funds Are Coming Back
finance.yahoo.com - October 27 at 1:18 PM
benzinga.com logoNautilus Biotechnology Shares Spike Higher On Volume; Traders Circulate Connection To Amazon
benzinga.com - September 10 at 3:57 AM
msn.com logoThese biotech and life sciences CEOs made the leap from software startups — here’s how they did it
msn.com - September 2 at 4:44 PM
msn.com logoSeattle startup Remitly reveals financial results in preparation for upcoming IPO
msn.com - August 30 at 10:40 PM
insidertrades.com logoInvestors Should Note These 3 Recent Insider Trades (NAUT)
insidertrades.com - August 24 at 8:07 PM
finance.yahoo.com logoNautilus Biotechnology Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 10 at 7:15 AM
marketwatch.com logoNautilus Biotechology Up 13% on CNBC Report About Amazon Investment
marketwatch.com - August 5 at 6:16 PM
msn.com logoNautilus Biotechnology shares surge 50% on news of Amazon investment
msn.com - August 5 at 6:16 PM
msn.com logoNautilus Biotechnology soars 65% after Amazon reveals a $15 million stake in the small-cap company
msn.com - August 5 at 6:16 PM
msn.com logoAmazon invested millions in a pre-revenue company with a system for measuring human proteins
msn.com - August 5 at 1:16 PM
finance.yahoo.com logoNautilus Biotechnology to Announce Second Quarter of Fiscal Year 2021 Financial Results on August 10, 2021
finance.yahoo.com - July 13 at 9:53 AM
msn.com logoAbsci’s IPO reflects booming biotech market and growing PNW life sciences industry
msn.com - July 8 at 11:49 AM
msn.com logoBiotech’s Race for Drug Development
msn.com - July 7 at 10:46 PM
bizjournals.com logoBiotech SPAC mergers are pumping big money into drugs and startups
bizjournals.com - July 1 at 1:22 PM
finance.yahoo.com logoNautilus Biotechnology Appoints Emma Lundberg, Ph.D., to Scientific Advisory Board
finance.yahoo.com - June 17 at 8:46 AM
forbes.com logoNew Technology Could Unlock The Secrets Of Every Protein In The Body
forbes.com - June 16 at 9:15 AM
Get Nautilus Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAUT and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.